286 related articles for article (PubMed ID: 36715552)
1. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Pongor LS; Schultz CW; Rinaldi L; Wangsa D; Redon CE; Takahashi N; Fialkoff G; Desai P; Zhang Y; Burkett S; Hermoni N; Vilk N; Gutin J; Gergely R; Zhao Y; Nichols S; Vilimas R; Sciuto L; Graham C; Caravaca JM; Turan S; Tsai-Wei S; Rajapakse VN; Kumar R; Upadhyay D; Kumar S; Kim YS; Roper N; Tran B; Hewitt SM; Kleiner DE; Aladjem MI; Friedman N; Hager GL; Pommier Y; Ried T; Thomas A
Cancer Discov; 2023 Apr; 13(4):928-949. PubMed ID: 36715552
[TBL] [Abstract][Full Text] [Related]
2. Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.
Pal Choudhuri S; Girard L; Lim JYS; Wise JF; Freitas B; Yang D; Wong E; Hamilton S; Chien VD; Kim YJ; Gilbreath C; Zhong J; Phat S; Myers DT; Christensen CL; Mazloom-Farsibaf H; Stanzione M; Wong KK; Hung YP; Farago AF; Meador CB; Dyson NJ; Lawrence MS; Wu S; Drapkin BJ
Cancer Discov; 2024 May; 14(5):804-827. PubMed ID: 38386926
[TBL] [Abstract][Full Text] [Related]
3. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.
Kim H; Nguyen NP; Turner K; Wu S; Gujar AD; Luebeck J; Liu J; Deshpande V; Rajkumar U; Namburi S; Amin SB; Yi E; Menghi F; Schulte JH; Henssen AG; Chang HY; Beck CR; Mischel PS; Bafna V; Verhaak RGW
Nat Genet; 2020 Sep; 52(9):891-897. PubMed ID: 32807987
[TBL] [Abstract][Full Text] [Related]
4. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
5. Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer.
Yi E; Gujar AD; Guthrie M; Kim H; Zhao D; Johnson KC; Amin SB; Costa ML; Yu Q; Das S; Jillette N; Clow PA; Cheng AW; Verhaak RGW
Cancer Discov; 2022 Feb; 12(2):468-483. PubMed ID: 34819316
[TBL] [Abstract][Full Text] [Related]
6. ecDNA hubs drive cooperative intermolecular oncogene expression.
Hung KL; Yost KE; Xie L; Shi Q; Helmsauer K; Luebeck J; Schöpflin R; Lange JT; Chamorro González R; Weiser NE; Chen C; Valieva ME; Wong IT; Wu S; Dehkordi SR; Duffy CV; Kraft K; Tang J; Belk JA; Rose JC; Corces MR; Granja JM; Li R; Rajkumar U; Friedlein J; Bagchi A; Satpathy AT; Tjian R; Mundlos S; Bafna V; Henssen AG; Mischel PS; Liu Z; Chang HY
Nature; 2021 Dec; 600(7890):731-736. PubMed ID: 34819668
[TBL] [Abstract][Full Text] [Related]
7. Defining the Role of Extrachromosomal DNA Amplifications in Medulloblastoma.
Zhao D; Verhaak RGW
Cancer Res; 2024 Feb; 84(4):515-516. PubMed ID: 38175761
[TBL] [Abstract][Full Text] [Related]
8. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ
Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406
[TBL] [Abstract][Full Text] [Related]
9. Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer.
Patel AS; Yoo S; Kong R; Sato T; Sinha A; Karam S; Bao L; Fridrikh M; Emoto K; Nudelman G; Powell CA; Beasley MB; Zhu J; Watanabe H
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33514539
[TBL] [Abstract][Full Text] [Related]
10. Progress on the role of extrachromosomal DNA in tumor pathogenesis and evolution.
Xing J; Ning Q; Tang D; Mo Z; Lei X; Tang S
Clin Genet; 2021 Apr; 99(4):503-512. PubMed ID: 33314031
[TBL] [Abstract][Full Text] [Related]
11. Family matters: How MYC family oncogenes impact small cell lung cancer.
Brägelmann J; Böhm S; Guthrie MR; Mollaoglu G; Oliver TG; Sos ML
Cell Cycle; 2017 Aug; 16(16):1489-1498. PubMed ID: 28737478
[TBL] [Abstract][Full Text] [Related]
12. Extrachromosomal DNA amplifications in cancer.
Yi E; Chamorro González R; Henssen AG; Verhaak RGW
Nat Rev Genet; 2022 Dec; 23(12):760-771. PubMed ID: 35953594
[TBL] [Abstract][Full Text] [Related]
13. Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of
Choudhuri SP; Girard L; Lim JYS; Wise JF; Freitas B; Yang D; Wong E; Hamilton S; Chien VD; Gilbreath C; Zhong J; Phat S; Myers DT; Christensen CL; Stanzione M; Wong KK; Farago AF; Meador CB; Dyson NJ; Lawrence MS; Wu S; Drapkin BJ
bioRxiv; 2023 Jun; ():. PubMed ID: 37425738
[TBL] [Abstract][Full Text] [Related]
14. MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study.
Alves Rde C; Meurer RT; Roehe AV
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2021-5. PubMed ID: 25012251
[TBL] [Abstract][Full Text] [Related]
15. The evolutionary dynamics of extrachromosomal DNA in human cancers.
Lange JT; Rose JC; Chen CY; Pichugin Y; Xie L; Tang J; Hung KL; Yost KE; Shi Q; Erb ML; Rajkumar U; Wu S; Taschner-Mandl S; Bernkopf M; Swanton C; Liu Z; Huang W; Chang HY; Bafna V; Henssen AG; Werner B; Mischel PS
Nat Genet; 2022 Oct; 54(10):1527-1533. PubMed ID: 36123406
[TBL] [Abstract][Full Text] [Related]
16. Amplification and expression of the c-myc oncogene in human lung cancer cell lines.
Little CD; Nau MM; Carney DN; Gazdar AF; Minna JD
Nature; 1983 Nov 10-16; 306(5939):194-6. PubMed ID: 6646201
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
[TBL] [Abstract][Full Text] [Related]
18. MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
Ireland AS; Micinski AM; Kastner DW; Guo B; Wait SJ; Spainhower KB; Conley CC; Chen OS; Guthrie MR; Soltero D; Qiao Y; Huang X; Tarapcsák S; Devarakonda S; Chalishazar MD; Gertz J; Moser JC; Marth G; Puri S; Witt BL; Spike BT; Oliver TG
Cancer Cell; 2020 Jul; 38(1):60-78.e12. PubMed ID: 32473656
[TBL] [Abstract][Full Text] [Related]
19. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
[TBL] [Abstract][Full Text] [Related]
20. Human small-cell lung cancers show amplification and expression of the N-myc gene.
Nau MM; Brooks BJ; Carney DN; Gazdar AF; Battey JF; Sausville EA; Minna JD
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1092-6. PubMed ID: 2869482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
